PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

HL HL9139

NHS: Drugs

answeredUnited Kingdom· UK Parliament· EN

Introduced

4 July 2025

Last action

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

12 August 2025

Summary

To ask His Majesty's Government what steps they are taking to ensure that the pricing and reimbursement of multi-indication medicines does not deter future investment in UK-based research and development or the launches of new medicines.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.